CAS 257938-36-6

N-(4-Bromo-2-fluorophenyl)-7-[2-(1H-1,2,3-triazol-1-yl)ethoxy]-6-methoxyquinazoline-4-amine hydrochloride

Description:

N-(4-Bromo-2-fluorophenyl)-7-[2-(1H-1,2,3-triazol-1-yl)ethoxy]-6-methoxyquinazoline-4-amine hydrochloride is a synthetic organic compound characterized by its complex structure, which includes a quinazoline core, a triazole moiety, and various halogen substituents. This compound typically exhibits properties such as solubility in polar solvents, which is common for many hydrochloride salts, and may demonstrate biological activity due to its structural features that can interact with biological targets. The presence of bromine and fluorine atoms suggests potential for enhanced lipophilicity and biological activity, while the triazole group may contribute to its pharmacological properties. As a hydrochloride salt, it is likely to be more stable and easier to handle compared to its free base form. This compound may be of interest in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific diseases, although detailed studies would be necessary to elucidate its full biological profile and potential applications.

Formula: C₁₉H₁₇BrClFN₆O₂

Synonyms:

• ZD-4190
• ZD-4190 hydrochloride
• ZD4190 HCl
• 4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[2-(1H-1,2,3-triazol-1-yl)ethoxy]-, hydrochloride (1:1)
• ZD-4190 HCl

ZD4190 HCl

CAS: 257938-36-6

ZD-4190, a potent VEGFR inhibitor, prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues.

Formula: C₁₉H₁₇BrClFN₆O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 495.73

Ref: TM-T29209